Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23 EUR | +0.88% |
|
-4.96% | -20.14% |
06-28 | Would you like some more inflation? | ![]() |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
122B | ||||||
113B | ||||||
26.22B | - | |||||
19.01B | - | |||||
15.22B | - |